Facebook Twitter LinkedIn Google Plus RSS

FTC clears Actavis acquisition of Warner Chilcott

By ,

Parsippany-based specialty pharmaceutical company Actavis announced Friday the Federal Trade Commission approved the acquisition of Warner Chilcott by Actavis. The vote in support of the transaction follows Actavis' agreement to a proposed consent order, pursuant to which Actavis has agreed to divest certain products as a condition to obtaining FTC approval.

According to the announcement, the closing of the transaction remains subject to approval by the Irish High Court and other customary closing conditions. Under the terms of the deal, Actavis will divest four products to Amneal Pharmaceuticals. Terms of the divestitures were not disclosed.

Actavis shareholders approved the acquisitions earlier this month.

Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy